{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:52:09Z","timestamp":1791348729219,"version":"4.3.1"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To develop a machine learning\u2013based predictive model for acute-on-chronic liver failure (ACLF) risk in patients with decompensated cirrhosis using baseline clinical indicators at hospital admission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>This retrospective cohort included 360 decompensated cirrhosis patients with intensive monitoring needs or infection\/circulatory risk factors, randomly divided into training and validation sets at a 7:3 ratio. Three models\u2014random forest, support vector machine, and logistic regression\u2014were constructed. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), calibration curves, and decision curve analysis (DCA). SHapley Additive exPlanations (SHAP) were employed for model interpretability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In the training set, 52 patients (20.6%) experienced ACLF. Multivariate analysis identified total bilirubin (TBil) (OR\u2009=\u20091.051, 95% CI: 1.030\u20131.073,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001), arterial lactate (OR\u2009=\u20091.341, 95% CI: 1.058\u20131.700,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.015), and white blood cell count (WBC) (OR\u2009=\u20091.111, 95% CI: 1.007\u20131.227,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.036) as independent risk factors, whereas prothrombin time activity (PTA) (OR\u2009=\u20090.961, 95% CI: 0.941\u20130.982,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001) was protective. The random forest model showed comparable performance to logistic regression with training\/validation AUCs of 0.833 (95% CI: 0.757\u20130.910) and 0.700 (95% CI: 0.555\u20130.845). All models showed acceptable discrimination and net clinical benefit on DCA. Calibration was good in the training set but moderate in the validation set (calibration slopes 0.580\u20130.620). SHAP importance ranking placed PTA, TBil, WBC, and lactate as the top predictors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The random forest model showed acceptable training performance, but the wide validation AUC confidence interval suggests limited stability, likely due to small sample size and few events. External validation is needed before clinical use. Nonetheless, the model shows potential for early warning and risk stratification in decompensated cirrhosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1948234","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:49:32Z","timestamp":1791348572000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Machine learning model for ACLF risk in decompensated cirrhosis"],"prefix":"10.3389","volume":"13","author":[{"given":"Liwen","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Henan Provincial People\u2019s Hospital, Zhengzhou University People\u2019s Hospital","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Henan Provincial People\u2019s Hospital, Zhengzhou University People\u2019s Hospital","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Henan Provincial People\u2019s Hospital, Zhengzhou University People\u2019s Hospital","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1136\/gutjnl-2020-322161","article-title":"Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis","volume":"71","author":"Mezzano","year":"2022","journal-title":"Gut"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1016\/j.cgh.2024.04.018","article-title":"Definitions, etiologies, and outcomes of acute on chronic liver failure: a systematic review and meta-analysis","volume":"22","author":"Aggarwal","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.4254\/wjh.v14.i12.2025","article-title":"CLIF-SOFA and CLIF-C scores for the prognostication of acute-on-chronic liver failure and acute decompensation of cirrhosis: a systematic review","volume":"14","author":"Rashed","year":"2022","journal-title":"World J Hepatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jhep.2023.04.021","article-title":"EASL clinical practice guidelines on acute-on-chronic liver failure","volume":"79","author":"Moreau","year":"2023","journal-title":"J Hepatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.cld.2020.01.010","article-title":"Clinical manifestations of hepatic encephalopathy","volume":"24","author":"Dellatore","year":"2020","journal-title":"Clin Liver Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.3350\/cmh.2025.0573","article-title":"Predictive machine learning model in intensive care unit patients with acute-on-chronic liver failure and two or more organ failures","volume":"31","author":"Yeo","year":"2025","journal-title":"Clin Mol Hepatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.jhep.2023.07.011","article-title":"Metabolic biomarkers significantly enhance the prediction of HBV-related ACLF occurrence and outcomes","volume":"79","author":"Zhang","year":"2023","journal-title":"J Hepatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/liv.15361","article-title":"APASL-ACLF research consortium-artificial intelligence (AARC-AI) model precisely predicts outcomes in acute-on-chronic liver failure patients","volume":"43","author":"Verma","year":"2023","journal-title":"Liver Int"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1111\/jvh.13747","article-title":"MELD score<18 rule out 28-day ACLF development among inpatients with hepatitis B-related previous compensated liver disease","volume":"29","author":"Qi","year":"2022","journal-title":"J Viral Hepat"},{"key":"B11","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1053\/jhep.2002.31250","article-title":"Hepatic encephalopathy\u2013definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th world congresses of gastroenterology, Vienna, 1998","volume":"35","author":"Ferenci","year":"2002","journal-title":"Hepatology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/ueg2.12538","article-title":"Acute decompensation of cirrhosis versus acute-on-chronic liver failure: what are the clinical implications?","volume":"12","author":"Xu","year":"2024","journal-title":"United European Gastroenterol J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1016\/j.jhep.2020.12.005","article-title":"Transition to decompensation and acute-on-chronic liver failure: role of predisposing factors and precipitating events","volume":"75","author":"Gustot","year":"2021","journal-title":"J Hepatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"458","DOI":"10.14218\/JCTH.2021.00202","article-title":"Development and validation of a nomogram for 90-day outcome in patients with hepatitis B virus-related acute-on-chronic liver failure","volume":"10","author":"Yang","year":"2022","journal-title":"J Clin Transl Hepatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12876-022-02351-5","article-title":"Establishment of MELD-lactate clearance scoring system in predicting death risk of critically ill cirrhotic patients","volume":"22","author":"Li","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"389","DOI":"10.17085\/apm.23048","article-title":"Neutrophilia is more predictive than increased white blood cell counts for short-term mortality after liver transplantation in patients with acute-on-chronic liver failure","volume":"18","author":"Kim","year":"2023","journal-title":"Anesth Pain Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e15861","DOI":"10.1111\/liv.15861","article-title":"Acute and non-acute decompensation of liver cirrhosis","volume":"45","author":"McCoy","year":"2025","journal-title":"Liver Int"},{"key":"B18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/lt.25913","article-title":"The predictive role of model for end-stage liver disease-lactate and lactate clearance for in-hospital mortality among a national cirrhosis cohort","volume":"27","author":"Mahmud","year":"2021","journal-title":"Liver Transpl"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/j.dld.2024.06.029","article-title":"Predicting the 28-day prognosis of acute-on-chronic liver failure patients based on machine learning","volume":"56","author":"Qiu","year":"2024","journal-title":"Dig Liver Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12876-025-03697-2","article-title":"Development and validation of an interpretable machine learning model for predicting the risk of hepatocellular carcinoma in patients with chronic hepatitis B: a case-control study","volume":"25","author":"Wu","year":"2025","journal-title":"BMC Gastroenterol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1948234\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:49:35Z","timestamp":1791348575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1948234\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":20,"alternative-id":["10.3389\/fmed.2026.1948234"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1948234","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"article-number":"1948234"}}